Skip to main content
Journal of Clinical Orthopaedics and Trauma logoLink to Journal of Clinical Orthopaedics and Trauma
. 2019 Nov 5;11(Suppl 2):S255–S259. doi: 10.1016/j.jcot.2019.10.012

Incidence and risk factors of acute kidney injury after total joint arthroplasty; a retrospective cohort study

Izziddine Ahmad Ali Vial a,, Tehmoor Babar a, Ihab Boutros b
PMCID: PMC7068025  PMID: 32189950

Abstract

Background

Acute Kidney Injury (AKI) is a common complication post-arthroplasty, although it has not been extensively studied. We carried out a retrospective study to determine the incidence and risk factors of AKI in patients undergoing total joint arthroplasty (TJA).

Method

We reviewed the medical records of all patients who underwent elective TJA from December 2014 to January 2017 at the Salford Royal Hospital, UK. AKI was defined using the AKIN, RIFLE and KDIGO criteria in patients with worsened renal function post-arthroplasty. We analysed the association of the demographics, risk factors, medications and use of peri-operative IV fluids with AKI. A logistic regression was performed to find any correlation between these factors and incidence of AKI.

Results

197 patients were included in our study, the mean age was 70.2 and male to female ratio was 6:5. Of these, 32(16.2%) developed an AKI. The multivariate logistic regression revealed 4 independent factors associated with the risk of AKI; age (P = 0.0011, OR 1.07, 95% CI 1.03–1.18), obesity (P = 0.003, OR 6.4, 95% CI 2.34–17.5), smoking (P = 0.0482, OR 3.76, 95% CI 1.01–14.0) and COPD (P = 0.0253, OR 3.85, 95% CI 1.18–12.5).

Conclusion

The incidence of AKI post-arthroplasty was found to be much higher than stated in other literatures. The recognition of the high incidence and multiple independent risk factors will allow a better approach to peri-operative management, limiting the risks of AKI. Our study also highlighted the importance of documenting urine output and the need to repeat the renal function test 3 months after an AKI to assess recovery.

1. Introduction

Total joint arthroplasty (TJA) is one of the most common type of orthopaedic surgical procedure performed. It is expected that the demand for primary and revision arthroplasties is going to keep growing in the coming years.1,2 In 2016, 101, 651 hip arthroplasties and 108, 713 knee arthroplasties were performed in the United Kingdom.3 As the number of arthroplasties keeps increasing annually, the number of complications associated with them is also on the rise. One of the most common complication is postoperative acute kidney injury (AKI).4

Postoperative AKI affects 0.5–14.8% of patients undergoing TJA.4, 5, 6, 7, 8 The big range in the incidence of AKI may be because of some studies including both elective and trauma patients in their studies and others including only elective patients. Incidence of AKI among elective orthopaedic patients is much lower compared to incidence of AKI among both elective and trauma orthopaedic patients.5,9 AKI patients have a higher hospital mortality than non-AKI patients.10, 11, 12 Even after recovery of their renal functions, AKI patients have a higher degree of mortality than non-AKI patients.13

The aetiology of postoperative AKI is believed to be multifactorial. Previous studies identified some preoperative risk factors linked to postoperative AKI. They include elevated body mass index (BMI), vascular disease, hypertension (HTN), diabetes mellitus, congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), angiotensin converting enzymes inhibitors (ACEi), angiotensin receptor blockers (ARBs) and age.5, 6, 7, 8,14,15

General anaesthesia and blood transfusion have been identified to be perioperative predictors of postoperative AKI.5

In majority of literatures about AKI post-arthroplasty, there is coherent evidence that some definite factors increase the risk of AKI. However, in a few papers there is also inconsistency regarding some predictors.

We performed an audit on patients who underwent primary and revision arthroplasties at Salford Royal Hospital, United Kingdom between December 2014 and January 2017. The aim of the study was to:

  • (1)

    Calculate the incidence of patients suffering from AKI after the changes made from the 2014 audit.

  • (2)

    Find out the major pre- and perioperative risk factors of AKI in the cohort of patients.

The 2014 audit found that 18% of arthroplasty patients suffered from renal injury. The proposed plan was to halve the dose of gentamicin given prophylactically from 2 mg to 1 mg.

2. Method

2.1. Design and subjects

The charts of 197 patients who underwent a hip or knee arthroplasty between December 2014 and January 2017 inclusive were retrospectively reviewed at our institution, a big tertiary teaching hospital in Manchester, United Kingdom. The patients had either undergone primary or revision arthroplasty. All patients had undergone an elective procedure. These patients were selected from the Electronic Patient records (EPR). Inclusion criteria was more than 18 years of age. In the UK, no approval from the ethics committee of the hospital is required for an audit.

2.2. Assessment of AKI

The main aim of the study was to find the incidence of postoperative AKI among the TJA patients. Diagnosis of AKI was made using the Risk, Injury, Failure, Loss of kidney function and End-stage criteria (RIFLE) criteria,16 Acute Kidney Injury Network (AKIN) criteria17 and Kidney Disease Improving Global Outcome (KDIGO) criteria.18

Table 1 shows the three classifications and staging of AKI according to RIFLE, AKIN and KDIGO.

Table 1.

Classification of AKI.

Classification RIFLE AKIN KDIGO
Stage Risk
Increased Serum creatinine (SCr) x 1.5 or GFR decrease > 25% or urine output < 0.5 ml/kg/h for 6 h
Stage 1
Increased sCr × 1.5 or ≥ 0.3 mg/dl from baseline or urine output < 0.5 ml/kg/h for 6 h
Stage 1
Increased sCr × 1.5 to 1.9 baseline or ≥ 0.3 mg/dl from baseline or urine output < 0.5 ml/kg/h for 6–12 h
Injury
Increased SCr × 2 or GFR decrease > 50% or urine output < 0.5 ml/kg/h for 12 h
Stage 2
Increased sCr × 2 or urine output < 0.5 ml/kg/h for 12 h
Stage 2
Increased sCr × 2.0 to 2.9 baseline or urine output < 0.5 ml/kg/h for 12 h
Failure
Increased sCr × 3 or GFR decrease > 75% or sCr ≥ 4 mg/dl (acute rise of sCr ≥ 0.5 mg/dl) or urine output < 0.3 ml/kg/h for 24 h or anuria for 12 h
Stage 3
Increased sCr × 3 or ≥ 4 mg/dl with acute rise of sCr ≥ 0.5 mg/dl or urine output < 0.3 ml/kg/h for 24 h or anuria for 12 h
Stage 3
Increased sCr × 3 baseline or ≥ 4 mg/dl or initiation of RRT, or GFR decrease < 35 ml/min/1.73 m2 for patients < 18 years of age or urine output < 0.3 ml/kg/h for 24 h or anuria for 12 h
Loss
Persistent AKI > 4 weeks ESRD End-stage renal disease

The diagnosis of postoperative AKI was made by comparing the baseline and highest postoperative sCr. Usually, preoperative sCr is obtained during the pre-op appointment which happens within 3 months of surgery. Postoperative sCr is usually obtained by the surgical team during a time period of 72 h after surgery. Patients meeting any of the criteria describe above was diagnosed as having postoperative AKI. Urine output was not used as a diagnostic tool as it was not properly recorded during surgery and on postoperative wards.

2.3. Data collection

Comorbidities, age, gender, BMI > 30 (obesity), smoking status, past medical history and pre-operative renal function (measured by serum creatinine and estimated glomerular filtration rate (eGFR)) were collected and recorded. Comorbidities recorded are chronic obstructive pulmonary disease (COPD), type 2 diabetes mellitus (T2DM), chronic kidney disease (CKD)/renal dysfunction, hypertension (HTN) and hypothyroidism. Data on medication such as ACEi, ARBs, diuretics, potassium sparing, statins, beta blockers, prednisolone, PPI and NSAIDs were abstracted from the medication charts. Operative data including volume of intraoperative fluid administered was also collected.

2.4. Data analysis

Explanatory variables were identified following a systematic review of the literature. A PubMed database search was done to find previous studies, also in the Elsevier database. The search terms used were as follows: “kidney injury”, “kidney failure”, “kidney dysfunction”, “arthroplasty”, “risk factors”, “hip replacement”, “knee replacement” and “postoperative”. Thereafter, the literatures were manually reviewed to identify studies that investigated postoperative AKI following total joint arthroplasty.4, 5, 6,8,9,19

Mean and standard deviations were calculated for continuous variables.

Univariate comparison was performed using the univariate logistic regression. It was performed on all potential risk factors. Multivariate comparison was then done using the multivariate logistic regression. It was performed to identify risk factors causing postoperative AKI. Predictors having a P value of < 0.05 were considered to be statistically significant. The study found that age, obesity, smoking and COPD were independent risk factors of postoperative AKI. Statistical analysis was performed using Stats Direct.

3. Results

Table 2 shows factors associated with the development of AKI post-TJA 197 patients were retrospectively reviewed in the audit, including 90 males and 107 females with a mean age of 70.2 (S.D = 11.8). 32 patients (16.2%) suffered from postoperative complication of AKI. Demographic, pre-operative, intra-operative and post-operative information of patients with or without AKI can be found in Table 1.

Table 2.

Potential risk factors.

Normal Variable All patients Post operative AKI, n = 32 No post operative AKI, n = 135 Logistic Regression
Univariate
Multivariate
O.R (95%CI) P value O.R (95% CI) P value
Age
 Mean 70.2 72.8 69.7 10.2(0.99–1.06) 0.166 1.07(1.03–1.18) 0.0011
 Standard Deviation 11.8 10.2 12.1
Gender
 Male 90 14 76 0.89(0.41–1.91) 0.7621 0.67(0.30–1.53) 0.3443
 Female 107 18 89
Obese*
 Yes 105 26 79 4.72(1.84–12.1) 0.0012 6.40(2.34–17.5) 0.003
 No 92 6 86
Smoking*
 Yes 22 5 17 1.61(0.55–4.74) 0.3853 3.76(1.01–14.0) 0.0482
 No 175 27 148
COPD*
 Yes 18 7 11 3.92(1.39–11.1) 0.0099 3.85(1.18–12.5) 0.0253
 No 179 25 154
T2DM
 Yes 33 9 24 2.30(0.95–5.56) 0.0649 1.19(0.42–3.33) 0.7469
 No 164 23 141
CKD/Renal dysfunction
 Yes 18 7 11 1.67(0.61–4.56) 0.3147 0.88(0.25–3.09) 0.8425
 No 179 25 154
HTN
 Yes 87 18 69 1.79(0.83–3.84) 0.1357 1.01(0.43–2.35) 0.9817
 No 10 14 96
Hypothyroidism
 Yes 24 3 21 0.71(0.20–2.54) 0.5972 0.59(0.15–2.38) 0.4593
 No 173 29 144
ACEI/ARBS
 Yes 53 13 40 2.07(0.94–4.55) 0.0708 1.67(0.56–4.98) 0.4593
 No 144 19 125
Loop diuretics
 yes 23 4 19 1.10(0.35–3.47) 0.8739 1.44(0.45–4.61) 0.3552
 No 174 28 146
Thiazide diuretics
 Yes 19 3 16 0.96(0.26–3.52) 0.955 0.53(0.14–2.11) 0.5387
 No 178 29 49
Potassium Sparing diuretics
 Yes 8 1 7 0.73(0.086–6.13) 0.7703 2.16(0.25–18.6) 0.4824
 No 189 31 158
Statin
 Yes 76 18 58 2.37(1.10–5.11) 0.0275 1.41(0.57–3.47) 0.4576
 No 121 14 107
B-blocker
 Yes 43 10 33 1.82(0.79–4.21) 0.1626 1.69(0.57–5.02) 0.3487
 No
Prednisolone
 Yes 4 2 2 5.43(0.74–40.1) 0.0969 4.52(0.54–37.6) 0.1622
 No
PPI
 Yes 82 13 69 0.95(0.44–2.06) 0.9003 0.60(0.26–1.42) 0.2485
 No 15 19 96
NSAIDs
 Yes 22 7 15 2.80(1.04–7.55) 0.0419 2.57(0.98–6.72) 0.0547
 No 175 25 150
Intraoperative fluid administered (missing = 44) missing = 35 missing = 9
 Mean 1600 1603 1587 1.00(1.00–1.00) 0.5182
 Standard deviation 853 851 887

Univariate logistic regression was performed for all the potential risk factors of AKI and the results are shown in Table 1. Obesity (OR, 4.72; P = 0.0012), COPD (OR, 3.92; P = 0.0099), NSAIDs (OR, 2.8; P = 0.0419) and statin (OR, 2.37; P = 0.0275) were significant risk factors for renal impairment after total joint arthroplasty on univariate analysis.

Generalised multivariate logistic regression was then conducted on all the potential risk factors. Intraoperative fluid administered could not be added to the multivariate logistic regression and thus, multivariate logistic regression results could not be obtained. Age (OR, 1.07; P = 0.0011), obesity (OR, 6.40; P = 0.0003), smoking (OR, 3.76; P = 0.0482) and COPD (OR, 3.85; P = 0.0253) were identified as being significant risk factors of postoperative AKI.

4. Discussion

This is to the best of my knowledge the first study to look at the incidence of AKI and the relationship between AKI, intraoperative fluid administration, urine output and significant co-morbidities in patients undergoing hip and knee arthroplasties.

The main findings of the audit in patients undergoing arthroplasties are:

  • AKI is common in the early postoperative timeline.

  • Age, obesity, smoking and COPD have been found to be independent risks of developing postoperative AKI.

4.1. Incidence of AKI

Overall, AKI was found to be present in 16.2% of the patients within 72 h of the surgical procedure. The incidence reported was much higher compared to other studies (2%–5%).8The main reason why there may be so much disparity in the rate of incidence between the studies is because of the use of different criteria used to assess kidney damage in the patients. At the moment, there is no definite meaning for acute kidney injury.20

Renal insufficiency, renal dysfunction and acute renal failure (ARF) are examples of different terms used in literatures which describe AKI.21 As there is no general agreement on the definition of AKI, this prevents the comparison of clinical studies.9 This has given rise to major restriction in clinical success. However, in order to standardise AKI, the Acute Dialysis Quality Initiative (ADQI) group in 2002 suggested the RIFLE (Risk, Injury, Failure, Loss and End-stage kidney disease) criteria to address this technical shortcoming. This was proposed as a definition and staging method for AKI.16 Later on, the AKIN criteria was developed which came up with the acute kidney injury term. According to AKIN criteria, AKI is diagnosed if a patients has a 0.3 mg/dl or a 50% or more increase in serum creatinine (Scr) from its baseline or there is a reduction in urine output of less than 0.5  ml/kg/h over a period of 6 h, after appropriate fluid resuscitation.17

The higher rate of incidence of AKI among arthroplasty patients may also be due to the inclusion of patients with kidney dysfunction compared to other studies where only patients with healthy kidneys were studied.6,8,19 AKIN and RIFLE criteria were used to diagnose patients in the study and obtained 16.2% of AKI patients in the study. A retrospective study performed by Jiang et al. revealed an incidence of 6.8% of acute kidney disease (AKD). The study consisted of patients with no prior kidney abnormality and it assessed AKD using the RIFLE criteria, more precisely, increase in Scr was used to establish the degree of renal impairment.4Weingarten et al. conducted a retrospective study consisting of 9171 patients who underwent elective TJA. 167 (1.82%) patients suffered from AKI within 72 h after the surgical procedure. AKI was assessed using a modified AKIN.5 Jafari et al. had an incidence of 0.40% renal injury in a cohort of patients of 17 938. It was a retrospective study which made use of the RIFLE classification to define acute renal failure.8 58 cases of AKI were diagnosed in the retrospective study conducted by Jamsa et al. 18, 575 patients were included and Scr was used to categorise them into the different RIFLE grades.19 Kimmel et al. reported an incidence of 14.8% in the retrospective study she conducted. 425 elective patients who had primary, elective total joint arthroplasty formed part of the study. RIFLE criteria was used to assess AKI in the group of patients.6The incidence was lower in the retrospective cohort study conducted by Hassan. He reported an incidence of 2.7% in a study comprising of 599 patients who underwent primary total hip joint replacement.5

Right now, prevention is the only way to lower mortality and morbidity in postoperative AKI patients. Thus, appropriate policies can only be written after identification of the risk factors of postoperative AKI.5

4.2. Risk factors of AKI

In the study, obesity was found to be the most notable risk factor. Obese patients are 65% more likely to develop AKI compared to non-obese patients during the first month of admission.22 Glance et al. studied 300, 000 patients who just underwent general, vascular or orthopaedic surgery. He found that the risk of AKI was increased by 3–7 times in obese patients. Moreover, obese patients are associated with other comorbidities such as hypertension and diabetes which are also linked to postoperative AKI.9,23,24 Jiang et al., Jafari et al., Jamsa et al., Weingarten et al. and Kimmel et al. all concluded that a high BMI was a risk factor for postoperative AKI.5,6,8,19 Conversely, Hassan et al. did not have the same finding. His study did not find any correlation between obese patients and AKI although the BMI of patients range from 15 to 46.7

Numerous papers have reported age as being an independent risk factor for the development of postoperative AKI.6,7,19,25 Yet, Mehdi et al. did not come to the same conclusion and his study analysed more patients than the one listed above.

Smoking and COPD are not known risk factors of AKI.26 However, Jafari et al. found COPD to be linked to the incidence of AKI in postsurgical arthroplasty patients.8 Apart from Jafari et al., no research have found COPD to be a predictor of postoperative AKI in arthroplasty patients.

Contrary to numerous studies, hypertension has not been associated with postoperative AKI in the study.5,8,25 This may be due to the small number of patients analysed.

4.3. Study limitations

The study conducted has a few limitations. It was performed in a large tertiary care institution which covers quite a predominant white population. Generalisation is thus, limited to centres with a similar group of patients and surgical protocols. The audit is of retrospective nature which does not permit commitment to a specific anaesthetic or surgical protocol. Unfortunately, the urine output, and intraoperative blood loss could not be collected as it was not properly recorded or inexistent in the majority of documents. Similarly to other retrospective studies, unmeasured risk factors may also be linked to the incidence of AKI. 72 h postoperatively was decided to be the time period to diagnose AKI. This may have led to some AKI patients being missed as Scr may have increased after that timeframe. Finally, we did not do a follow-up of the patients who suffered from postoperative AKI. So, we do not know if they had fully or partially recovered from the disease. Yet, it has been written in papers that a high percentage of postoperative AKI patients get back to their original baseline Scr measurement. Ulucay et al. found that all patients who suffered from stage 1, 2 and 3 of AKI according to AKIN criteria, had full recovery of their renal function within a mean of 4.84 days (range 3–8 days).27

Another audit conducted by Courtney et al. demonstrated that patients who had AKI of stage 1, 2 and 3 under the AKIN criteria got back to 50% of their original Scr measurement within an average of 3 days.28 Those research papers prove that postoperative AKI patients have the capacity of regaining their full renal function.

5. Conclusion

My study, along with other studies, validates the high risk of suffering from renal dysfunction after a total hip or total knee joint arthroplasty.16.2% is quite a substantial percentage and policies need to be adopted to decrease the occurrence of AKI. Postoperative AKI has greater chance of occurring in patients with significant comorbidities.

Other studies need to be conducted to look at the relationship of urine output and AKI, a larger cohort of patients need to be studied to obtain statistically significant results and AKI patients need to be followed to know if their kidney function return to normal after three months.

Declaration of competing interest

I.Vial, T.Babar and I.Boutros declare that they have no conflict of interest.

Contributor Information

Izziddine Ahmad Ali Vial, Email: izziddine.vial@student.manchester.ac.uk.

Tehmoor Babar, Email: tehmoor.babar@nhs.net.

Ihab Boutros, Email: Ihab.Boutros@srft.nhs.uk.

References

  • 1.Kurtz S., Ong K., Lau E., Mowat F., Halpern M. 2007. Projections of Primary and Revision Hip and Knee Arthroplasty in the United States from 2005 to 2030; pp. 780–785. [DOI] [PubMed] [Google Scholar]
  • 2.Prevalence of Primary and Revision Total Hip and Knee Arthroplasty in the United States from 1990 through 2002. 2005. pp. 1487–1497. [DOI] [PubMed] [Google Scholar]
  • 3.National Joint Registry . vol.1821. 2017. pp. 1–202.http://www.njrreports.org.uk/Portals/0/PDFdownloads/NJR.14th.Annual.Report.2017.pdf (2017 14th Annual Report - National Joint Registry for England, Wales, Northern Ireland and the Isle of Man). December 2016. Available from: [Google Scholar]
  • 4.Jiang E.X., Gogineni H.C., Mayerson J.L., Glassman A.H., Magnussen R.A., Scharschmidt T.J. Acute kidney disease after total hip and knee arthroplasty: incidence and associated factors. J Arthroplasty. 2017;32(8):2381–2385. doi: 10.1016/j.arth.2017.03.009. Available from: [DOI] [PubMed] [Google Scholar]
  • 5.Weingarten T.N., Gurrieri C., Jarett P.D. Acute kidney injury following total joint arthroplasty: retrospective analysis. Can J Anesth. 2012;59(12):1111–1118. doi: 10.1007/s12630-012-9797-2. [DOI] [PubMed] [Google Scholar]
  • 6.Kimmel L.A., Wilson S., Janardan J.D., Liew S.M., Walker R.G. Incidence of acute kidney injury following total joint arthroplasty: a retrospective review by RIFLE criteria. Clin Kidney J. 2014;7(6):546–551. doi: 10.1093/ckj/sfu108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Hassan B.K., Sahlström A., Dessau R.B.C. Risk factors for renal dysfunction after total hip joint replacement; a retrospective cohort study. J Orthop Surg Res. 2015;10(1):1–5. doi: 10.1186/s13018-015-0299-0. Available from: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Jafari S.M., Huang R., Joshi A., Parvizi J., Hozack W.J. Renal impairment following total joint arthroplasty. Who is at risk? J Arthroplasty. 2010;25(SUPPL. 6):49–53. doi: 10.1016/j.arth.2010.04.008. e2. Available from: [DOI] [PubMed] [Google Scholar]
  • 9.Kateros K., Doulgerakis C., Galanakos S.P., Sakellariou V.I., Papadakis S.A., MacHeras G.A. Analysis of kidney dysfunction in orthopaedic patients. BMC Nephrol. 2012;13(1) doi: 10.1186/1471-2369-13-101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Abelha F.J., Botelho M., Fernandes V., Barros H. Determinants of postoperative acute kidney injury. Crit Care. 2009;13(3):1–10. doi: 10.1186/cc7894. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Kheterpal S., Tremper K.K., Heung M. Development and validation of an acute kidney injury risk index for patients undergoing general surgery. Anesthesiology [Internet] 2009;110(3):505–515. doi: 10.1097/ALN.0b013e3181979440. http://anesthesiology.pubs.asahq.org/Article.aspx?doi=10.1097/ALN.0b013e3181979440 Available from: [DOI] [PubMed] [Google Scholar]
  • 12.K S., T K.K., E M.J. Predictors of postoperative acute renal failure after noncardiac surgery in patients with previously normal renal function. Anesthesiology. 2007;107(6):892–902. doi: 10.1097/01.anes.0000290588.29668.38. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed8&NEWS=N&AN=2007577756 Available from: [DOI] [PubMed] [Google Scholar]
  • 13.Loef B.G. Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J Am Soc Nephrol [Internet] 2004;16(1):195–200. doi: 10.1681/ASN.2003100875. http://www.jasn.org/cgi/doi/10.1681/ASN.2003100875 Available from: [DOI] [PubMed] [Google Scholar]
  • 14.Bell S., Dekker F.W., Vadiveloo T. Risk of postoperative acute kidney injury in patients undergoing orthopaedic surgery-development and validation of a risk score and effect of acute kidney injury on survival: observational cohort study. BMJ. 2015:351. doi: 10.1136/bmj.h5639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Nielson E., Hennrikus E., Lehman E., Mets B. Angiotensin axis blockade, hypotension, and acute kidney injury in elective major orthopedic surgery. J Hosp Med. 2014;9(5):283–288. doi: 10.1002/jhm.2155. [DOI] [PubMed] [Google Scholar]
  • 16.Bellomo R., Ronco C., Kellum J.A., Mehta R.L., Palevsky P. Acute Dialysis Quality Initiative workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204–R212. doi: 10.1186/cc2872. http://www.ncbi.nlm.nih.gov/pubmed/15312219%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC522841 Available from: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Mehta R.L., Kellum J.A., Shah S.V. vol.11. 2007. pp. 1–8. (Acute Kidney Injury Network : Report of an Initiative to Improve Outcomes in Acute Kidney Injury). 2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Journal O., The O.F., Society I., Nephrology O.F. Off J Int Soc Nephrol Kdigo Clin Pract Guidelines Acute Kidney Inj. 2012;2(1) [Google Scholar]
  • 19.Jämsä P., Jämsen E., Lyytikäinen L.-P., Kalliovalkama J., Eskelinen A., Oksala N. Risk factors associated with acute kidney injury in a cohort of 20,575 arthroplasty patients. Acta Orthop. 2017;88(4):370–376. doi: 10.1080/17453674.2017.1301743. https://www.tandfonline.com/doi/full/10.1080/17453674.2017.1301743 Available from: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Levey A.S., De Jong P.E., Coresh J. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int [Internet] 2011;80(1):17–28. doi: 10.1038/ki.2010.483. Available from: [DOI] [PubMed] [Google Scholar]
  • 21.Josephs S.A., Thakar C.V. vol.47. 2009. pp. 89–105. (Perioperative Risk Assessment, Prevention, and Treatment of Acute Kidney Injury). 4. [DOI] [PubMed] [Google Scholar]
  • 22.Green M.J., Peterson S.K., Baker M.W. NIH Public Access. 2005;7(4):221–229. [Google Scholar]
  • 23.Therapy C. 1986. Acute Renal Failure in the Surgical Patient; pp. 719–723. September 2002. [Google Scholar]
  • 24.Diachun C.A.B., Salloum R., Fleming F.J., Dick A.W. vol. 4. 2010. pp. 859–872. (Perioperative Outcomes Among Patients with the). Ph D. [DOI] [PubMed] [Google Scholar]
  • 25.Nergelius G., Vinge E., Grubb A. 2009. Renal Impairment after Hip or Knee Arthroplasty : Urinary Excretion of Protein Markers Studied in 59 Patients Renal Impairment after Hip or Knee Arthroplasty Urinary Excretion of Protein Markers Studied in 59 Patients; p. 6470. [Google Scholar]
  • 26.Selewski D.T., Symons J.M. Acute kidney injury. Pediatr Rev. 2014;35(1):30–41. doi: 10.1542/pir.35-1-30. http://pedsinreview.aappublications.org/cgi/doi/10.1542/pir.35-1-30 Available from: [DOI] [PubMed] [Google Scholar]
  • 27.Ulucay C., Eren Z., Kaspar E.C. Risk factors for acute kidney injury after hip fracture surgery in the elderly individuals. Geriatr Orthop Surg Rehabil. 2012;3(4):150–156. doi: 10.1177/2151458512473827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Courtney P.M., Melnic C.M., Zimmer Z., Anari J., Lee G.C. Addition of vancomycin to cefazolin prophylaxis is associated with acute kidney injury after primary joint arthroplasty. Clin Orthop Relat Res. 2015;473(7) doi: 10.1007/s11999-014-4062-3. 2197–203. Available from: [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Orthopaedics and Trauma are provided here courtesy of Elsevier

RESOURCES